Alternatives to OMGene

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

Gene therapy company developing treatments for rare inherited diseases.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

NewLimit is developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.